Abstract: Protein aggregation can follow different pathways, and these can result in different net aggregation rates and kinetic profiles. a-chymotypsinogen A (aCgn) was used as a model system to quantitatively and qualitatively assess an approach that combines ex situ size-exclusion chromatography (SEC) with in situ laser scattering (LS) to monitor aggregation vs. time. Aggregation was monitored for a series of temperatures and initial dimer (ID) levels for starting conditions that were primarily (> 97%) monomer, and under initial-rate conditions (limited to low monomer conversionless than 20% monomer mass loss), as these conditions are of most to interest to many pharmaceutical and biotechnology applications. SEC results show that modest decreases of ID levels can greatly reduce monomer loss rates, but do not affect the effective activation energy for aggregation. The normalized aggregation rates determined from LS were typically~1 order of magnitude higher than the corresponding rates from SEC. Furthermore, LS signals vs. time became variable and highly nonlinear with decreasing ID level, temperature, and/or total protein concentration. Temperaturecycling LS experiments showed this corresponded to conditions where dimer/oligomer "seeding" was suppressed, and high levels of reversible oligomers ("prenuclei") were formed prior to "nucleation" and growth of stable aggregates. In those conditions, aggregation rates inferred from LS and SEC are greatly different, as the techniques monitor different stages of the aggregation process. Overall, the results illustrate an approach for interrogating non-native protein aggregation pathways, and potential pitfalls if one relies on a single method to monitor aggregation-this holds more generally than the particular methods here.
Introduction
Protein aggregation is often deleterious in a number of contexts, including production of therapeutic proteins and industrial enzymes, [1] [2] [3] aggregationmediated diseases, [4] [5] [6] and storage and administration of protein-based therapies. 7 Non-native protein aggregation (hereafter referred to simply as aggregation) denotes the process of converting folded or native protein monomers to soluble or insoluble aggregates in which the constituent monomers have lost a significant portion of their native secondary and/or tertiary structure. Mechanistically, aggregation typically involves both reversible and irreversible steps. 8, 9 Figure 1 provides a schematic for steps that are often implicated in the early stages of nonnative aggregation mechanisms. These include: (i) some degree of unfolding/conformational change in the protein monomers; (ii) reversible self-association of two or more monomers; (iii) "nucleation" of the smallest stable aggregates, presumably via interdigitation of the amino acids on neighboring monomers to form stable intermolecular secondary structure such as beta-sheets. For simplicity, Figure 1 does not show additional steps such as irreversible growth of "nuclei" can via recruitment of additional monomers, as well as by aggregate-aggregate coalescence. [10] [11] [12] In some cases, [13] [14] [15] [16] steps (ii) and (iii) can be effectively circumvented by the addition of pre-existing stable aggregates (termed "seeds" by analogy to crystallization) if step (iv) is inherently much faster than the steps required to nucleate new aggregates. For many proteins of interest, aggregation is of practical relevance at sample conditions that favor the native state. Therefore, the concentrations of partly or fully unfolded intermediates are low compared to that for the folded state. If one is interested in controlling aggregation of proteins for long term storage (e.g., months or years) it is often necessary to perform accelerated stability testing by heating to elevated temperatures while still remaining well below the midpoint unfolding temperature (T m ) of the relevant domain. Doing so increases the population of partly or fully unfolded monomers, and thereby helps to increase the driving force for the subsequent steps in Figure 1 . 17, 18 As long as one remains at temperatures well below T m for a given solution condition, the large majority of monomers will be in the folded state. This makes it difficult to detect conformationally altered monomers or other intermediates using spectroscopic techniques. Furthermore, many techniques are only practical to implement at ambient or near-ambient conditions after a given sample has been "quenched" by cooling from higher temperatures. [19] [20] [21] As a result, models used to interpret aggregation rate data typically make assumptions regarding the relative concentration of aggregation intermediates such as those depicted in Figure 1 , because these species are relatively unstable and difficult to isolate or characterize. Small-angle scattering such as static laser scattering (SLS) offers a means to monitor aggregation in situ and in real time for sample conditions and temperatures of practical interest for biotechnology products. 22, 23 However, SLS typically provides only population-averaged quantities such as the weightaveraged molecular weight (M w ), with the common assumption that nonidealities from protein-protein and protein-solvent interactions can be neglected. Prior work in a number of laboratories showed that combining ex situ SLS with size-exclusion chromatography (SEC) allows one to constrain possible interpretations of aggregation kinetics in terms of mechanistic models. 12, [24] [25] [26] [27] [28] In order for such approaches to be robust, the populations of intermediates in stages (i) to (iii) in Figure 1 need to be much smaller than the concentrations of the folded monomer and the stable (irreversible) aggregates, such that those species contribute negligibly to the overall mass balance. 7, 9, 29 Recent results comparing aggregation rates from ex situ SEC with those from in situ SLS for a monoclonal antibody were consistent with that low-intermediate-population Figure 1 . Schematic illustration of the steps in non-native aggregation: (i) unfolding/conformational change of native (N) species to form monomers that are "reactive" (R) with respect to aggregation because of exposed amino acid sequence "hot spots"; (ii) reversible self-association of two or more partly unfolded or fully unfolded monomers (R 2 , R 3 . . . R n; n 5 number of monomers); (iii) Structural rearrangement to form the smallest stable species that are effectively irreversible (A n ) -i.e., the "nucleation stage." Reversible steps can occur prior to the nucleation step; dashed arrows intend to emphasize that steps (i) and (ii) can be kinetically bypassed to form irreversible species if the following steps are much faster and/or in case pre-existing stable aggregates ("seeds"). Aggregates can also grow irreversibly at later stages by addition of monomers to nuclei, and by coalescence of irreversible aggregates to form larger aggregates (not shown in the schematic) assumption, and therefore suggested that SLS can be used as a robust surrogate for SEC to quantify rates of monomer loss in applications such as pharmaceutical stability testing. 22 The present report illustrates a more general approach for combining SEC and in situ SLS to interrogate protein aggregation mechanisms, using a model protein (bovine a-chymotrypsinogen, aCgn) that has been shown to follow nucleation-dependent aggregation pathways with seeding effects at acid conditions (pH 3 to 5). 30 The remainder of the report is organized as follows. A process is first illustrated to reproducibly prepare aCgn samples with controlled initial dimer (ID) levels. The impact of ID, temperature, and total protein concentration on aggregation rates based on SEC is also shown. This is then compared to aggregation rates determined by laser scattering under initial-rate conditions. The importance of ID levels is highlighted, as well as an approach to interrogating early-stage aggregation events and "prenucleation" events by combining SEC, SLS, and alternative time-temperature programs. In the interest of space constraints, only key figures are provided below, with additional examples included in Supporting Information, and referenced throughout.
Results and Discussion
Prior work 32 had indicated that aCgn aggregation at elevated temperature resulted in dimers being converted to insoluble aggregates at pH 4.5 in sodium citrate buffer, however preliminary results indicated that aggregates remained soluble at pH 4.5 in sodium acetate buffer [cf., Supporting Information Fig. S1(A) ]. This qualitative behavior was also consistent with results for other proteins. [32] [33] [34] [35] As noted in Methods, attempts to purify dimer via chromatography for seeding experiments were unsuccessful, potentially because of issues with column interactions that limited resolution of monomer and aggregate species that are being investigated as part of future work. Therefore, a series of heat treatments in citrate buffer were used to create samples with successively less dimer, as suggested by prior work that showed protein aggregates were much less soluble in citrate buffers. 32 (see also Methods).
Figure 2(A) shows illustrative SEC chromatograms for monomeric aCgn protein after heat treatment in 10 mM citrate buffer, pH 4.5, to precipitate dimer. The chromatograms are for samples that were heated in citrate buffer, precipitates removed by centrifugation, and then exchanged from citrate to acetate buffer in preparation of samples for use below. The starting samples in Figure 2 (A) are those with residual dimer content from the supplier (2.3%, based on relative peak area in SEC). The curves in Figure 2 (A) correspond to different dimer contents obtained after heat treatment for different periods of time. The average and standard deviation for dimer fraction (by mass) obtained from different protein stock solutions were 2.31% 6 0.04%, 0.65% 6 0.02%, 0.35% 6 0.02%, 0.17% 6 0.03%, and 0.04% 6 0.003% for heating incubation times of 0, 7, 15, 30, and 120 min, respectively. Overall, the result is that heat treatment in citrate buffer allows one to reduce the amount of dimer in a consistent manner, as dimers coalesce to form larger, insoluble aggregates upon heat treatment [additional chromatograms are shown in Supporting Information Fig. S1 (B)]. 32 Intrinsic fluorescence spectra measured before and after sample preincubation show that no major structural changes can be detected. [cf., Supporting
To focus on conditions where soluble aggregates ("seeds") might be most prevalent, the subsequent experiments were intended for acetate buffer conditions, therefore it was useful to test whether the dimer levels would change upon buffer exchange from citrate to acetate conditions. Figure 2 (B) shows a quantitative comparison of dimer levels versus incubation time at 578C: one set of data is for samples that were heated in citrate buffer, centrifuged, and injected directly in SEC (black squares); the other set is for samples that were buffer-exchanged into acetate buffer after they were heated and centrifuged (gray diamonds). The results indicate that buffer exchange from citrate to acetate buffer did not alter the soluble aggregate levels. This provided a means to reliably prepare aCgn stock solutions in pH 4.5 acetate buffer with different levels of dimer. In what follows, complementary analysis by SEC and SLS is confined to samples in 10 mM acetate buffer pH 4.5, with different initial dimer (ID) content.
The effects of ID level were then considered in the context of aggregation rates (monomer loss rates) using SEC, as this is arguably the most widely used method for quantifying aggregation rates in a number of biotechnology applications. 36, 37 Using the PTIR methodology (see Methods), 22, 35 the initial rate for monomer loss was determined by incubating a given starting sample for a short time at a selected temperature (T) of interest. This was repeated for a series of temperatures (or done in parallel, see Methods). The resulting profiles for initial-monomer-loss or monomer-fraction-remaining are shown as a function of T in Supporting Information. This was done for two different total protein concentrations (2 and 10 mg/L), and for a series of ID levels [cf., Supporting Information Fig. S2(A,B) ].
The results show that faster aggregation rates are observed as one increases ID level, T, and/or total protein concentration. The initial rate coefficient (k obs ) was calculated for a given temperature based on the SEC results described in Methods. Figure 3 shows kobs vs. inverse temperature for two different ID levels (2% and 0.2%) for a total protein concentration of 2 mg/ mL. The results show that aCgn aggregation follows a reasonably Arrhenius temperature dependence. Analogous results were obtained for aCgn at 10 mg mL 21 (cf., Supporting Information Fig. S3 ). For a given ID level, the effective activation energy (E a ) was independent of protein concentration, within statistical uncertainty. However, the absolute k obs value at a given T and ID is systematically lower for the lower total protein concentration. Supporting Information Figure S3 shows that the E a values are effectively independent of ID level within statistical uncertainty for the higher total protein concentration, but are weakly dependent on ID level for the lower protein concentration. It was previously hypothesized that aggregation rates monitored with SLS over the initial-rate regime would provide equivalent information to those from SEC if the aggregation mechanism was reasonably simple. It was noted that this would theoretically depend on the importance of "seeding" effects, but that was not explored in the prior work. 22 Illustrative SLS data for samples with 2.3%
ID are shown in Figure 4 (A,B), in terms of M w /M 1 as a function of k obs 3 t for some of the same incubation temperatures shown in Figure 3 . Equations used to obtain apparent molecular weight (M w ) at a given time are shown in Supporting Information. The M w was compared with the absolute molecular weight of aCgn (M 1 5 25.7 KDa) to obtain the relative increase of M w /M 1 over time. The value of k obs for a given data set in Figure 4 is that for the corresponding sample condition from Figure 3 . Using a dimensionless time scale (k obs 3t) allows one to more easily interpret and compare monomer loss rates with M w increases vs. time from these different techniques. The data for a given temperature are shown as a common color and symbol type, with the data for at least 4 independent experiments overlaid for each case. In most cases, the data from independent runs overlay within the noise, while in a few cases (e.g., T 5 568C) the data deviate to a small degree at longer times from run to run [ Fig. 4(A) ]. As seen in Figure 4 (B), these variations are not observed at early times, and all the temperature conditions show linear behavior for M w /M 1 values below approximately 2, which is consistent with previous work for aggregation of monoclonal antibodies.
22,23
The upward curvature at later times in Figure 4 (A) is expected, as aggregates grow to larger sizes and likely also coalesce with each other. 17, 22, 32, 33 The linear regime obtained up to M w /M 1 2 [cf., Fig. 4(B) ] corresponds to the expected extent of monomer conversion to aggregates, based on k obs values from SEC-i.e., 1% monomer loss from SEC corresponds to a value of 0.01 on the x-axis of Figure 4(A,B) . The results in Figure 4 are all for relatively high ID levels (i.e., the starting levels in the commercial protein material). Figure 5 shows illustrative results for M w /M 1 vs. k obs 3 t for conditions with approximately ten-fold lower ID than those in Figure 4 . These are shown for illustration, with results from other ID levels summarized below. Unlike the results with higher ID, the results in Figure 5 show that profiles of M w vs. time can show a large degree of variability between repeated experiments at the same conditions. Qualitatively, the profiles in Figure 5 are also characterized by concave downward profiles that lead to a very large initial slope followed by a second smaller slope, and in some cases the M w effectively plateaus or even decreases slightly at times that correspond to rather low extents of monomer loss (k obs 3 t values very close to zero). As a result, the initial slope for all conditions in Figure 5 gives values for the apparent aggregation rate that are orders of magnitude higher than those from SEC. This is also evidenced by the much smaller x-axis values in Figure 5 compared to Figure 4 , as the time scales for increases in M w are much smaller than 1/k obs . Qualitatively, this suggests that the aggregation detected at early times in Figure 5 is reversed to some extent upon cooling of samples to the lower temperatures needed for SEC analysis. Quantitative comparisons of the apparent rates from SEC and SLS across a broader range of conditions are shown in Supporting Information. For some of the profiles in Figure 5 , there is an additional feature; at longer times the molecular weight increases nonlinearly (upward curvature). Qualitatively, this type of upturn [cf., Fig. 5(B) ] has been attributed to aggregate growth by monomer addition and by aggregate coalescence. 22 For aCgn at higher concentration (10 mg mL 21 ) with lower ID (0.17%), it was more common to observe concave upward behavior within the initial-rate regime [cf., Supporting Information Figure S4(A,B) ]. Based on the results above, it was hypothesized that cycling the temperature between high and low values would help to assess the degree to which reversible vs. irreversible aggregation steps contributed to the SLS profiles. Figure 6 shows illustrative SLS data when the temperature was cycled, stepwise, between constant high-temperature and constant cold-temperature "hold" stages. The arrows in the panels indicate when the temperature set-point was fixed at the "hot" temperature (red arrows) or "cold" temperature (blue arrows). The particular combinations of temperature and ID level in Figure  6 were chosen to compare cases where the isothermal data showed different behaviors. The top panel corresponds to conditions in Figure 5 , where SLS vs. time profiles showed primarily concave-down behavior, with initial aggregation rates on time scales much faster than those determined by SEC. The bottom panel corresponds to conditions where the SLS vs. time profiles were more simple and linear at early extents of reaction.
The results in Figure 6 (top) show that the LS signal decreases when samples were quenched to cold temperature and it increased back to earlier levels when the temperature was increased back to the original, higher temperature. This shows that decreasing temperature causes aggregates to dissociate, and in this case they dissociate almost completely back to the monomeric state. If one assumes that a single aggregate stoichiometry dominates, then the y-axis values suggest a dimer state, with almost all monomers converted to dimers in that case. Altenatively, the LS results are consistent with formation of larger reversible aggregate species (e.g., trimers and/or tetramers) but with only a portion of the monomers having been converted to aggregates. The LS data is inconclusive regarding the precise stoichiometry of the reversible aggregates.
Conversely, the bottom panel in Figure 6 illustrates a case where there was no discernable reversibility during temperature cycling experiments. In those cases, when the temperature was lowered, M w simply plateaued until the temperature was raised again. This indicates that if reversible oligomers were present at higher temperatures then they were at a sufficiently low level to not influence the measured LS signal. Therefore, the LS signal was effectively a combination of the contributions from primarily the monomers and the irreversible aggregates. In that case, interpretation of aggregation rates measured by LS is reasonable using the simple model proposed previously. 22 That is, Figure 6 . SLS time courses for aCgn aggregation obtained with cycles of heating and cooling. Red (blue) arrows indicate the time at which the temperature controller was set to a hot (cold) set point during the "step-and-hold" temperature cycling. Each plot corresponds to a different condition: (Top) aCgn 2 mg mL 21 with ID 5 0.17% heated at 51.58C and (Bottom) aCgn 10 mg mL 21 with ID 5 2.3% heated at 538C. The temperature used for the cooling step was 188C based on prior runs to optimize the instrument cooling rate. Gray circles and green diamonds data curves are duplicates in which heating and quenching steps were performed during the time course of aggregation for independently prepared samples while aggregates were "soluble" in all cases (all samples were transparent and did show sedimentation), these aggregates were effectively irreversible and any reversible intermediates were not discernable in these assays. However, more generally one should be cautions when using such models unless one first confirms the importance of reversible vs. irreversible aggregates, possibly using a temperature cycling approach such at that illustrated here. From a more fundamental perspective, it is also important to note that the manifestation of reversible aggregates was most prevalent when the ID levels were greatly reduced. Mechanistically, this is not surprising in hindsight, as high "seed" levels are expected to circumvent the need for "nucleation" of new aggregates. 16, [38] [39] [40] [41] In the particular case of aCgn, the results in Figure 6 (top panel) and the Supporting Information indicate the "prenuclei" are a mix of small oligomers (dimers, trimers, etc.). It was speculated in previous work that nuclei for aCgn aggregation were on the order of trimers and tetramers at pH 3.5, based on indirect evidence, 30, 31 but to the best of our knowledge the present results are first direct evidence of highly populated dimers or small oligomers as reversible and detectable prenuclei for aCgn. It is also striking that in some cases it appears that almost all of the protein is in an oligomeric state at high temperature, but converts almost completely back to monomer upon cooling if one does not wait for irreversible aggregates to form (cf., top panel in Fig. 6 ). Future work will focus on more detailed structural characterization of that reversible oligomeric state. All of the solution conditions in Figures 3-6 and the Supporting Information included multiple replicates (at least 4 in each case), so as to assess the variability in the observed kinetic profiles. In general, when simple linear behavior was observed, the temperature cycling measurements followed the behavior in Figure 6 (bottom) and vice versa for conditions where there was high variability (Fig. 6,  top) . The contour maps in Figure 7 show the probability of observing "complex" behavior such as that in Figure 5 , where the probability is defined as N c / N tot ; N c 5 the number of experiments at a given sample condition that showed complex behavior as in Figure 5 , and N tot 5 the total number of experiments. The results in Figure 7 span a range of temperatures and ID levels, for aCgn at 2 mg mL 21 (top panel) and 10 mg mL 21 (bottom panel). The dominant factors appear to be the ID level and total protein concentration, with the temperature having a weaker effect. Higher total protein concentration and/or ID levels corresponded to "simple" aggregation rate profiles in SLS, with less run-to-run variability and linear M w vs. t profiles, and vice versa for lower ID levels and/or lower total protein concentration.
Taken together, the results are consistent with the following qualitative mechanistic picture. As one heats aCgn, the monomer conformational equilibrium depicted in Figure 1 shifts such that partially and/or fully unfolded monomers are populated to a greater extent. For context, the midpoint unfolding temperature for aCgn at pH 4.5 is 638C for both citrate 32 and acetate buffer conditions (DSC data obtained here, not shown). The "onset temperature" (during scanning at 1C/min) is 558C, comparable to the highest temperature conditions used here. Therefore, most monomers would be expected to exist in folded conformers under the conditions shown above, if the system equilibrates rapidly. However, increasing the population of unfolded monomers drives reversible formation of small oligomers such as dimers, trimers, etc. Reducing the temperature causes the folding-unfolding transition(s) to shift toward the folded state and this depopulates any reversible species composed of Figure 7 . Contour plots of fraction (F) of observing "complex" aggregation behavior in SLS (e.g., large run-to-run variability, concave down profiles, and reversible aggregation upon cooling) for aCgn at 2 mg mL 21 (top) and 10 mg mL
21
(bottom) as a function of ID level and isothermal incubation temperature unfolded or partly unfolded protein chains. Those reversible species can be populated at levels comparable to the folded monomer concentration if they are not rapidly converted to irreversible aggregates (i.e., if they do not "nucleate" irreversible aggregates). 8, 19, 42 In some cases, the reversible aggregates appear to be the dominant species at high temperature, prior to conversion to irreversible aggregates, and this has gone unnoticed in prior work. In the present work, those aggregates appeared to be relatively small (e.g., dimers/trimers). However, one can only draw qualitative conclusions from these results since there could be a heterogeneous reversible aggregate population and SLS only reports on the weight-averged molecular weight in the low-q limit. In addition, more work is needed to address the question of the conformational state of the proteins in these reversible aggregates, within the constraints of the need to assess these at high concentrations and elevated temperatures in situ. SLS signals are most sensitive to larger species. [43] [44] [45] Therefore, if pre-existing aggregates ("seeds") can grow by addition of monomers or by addition of other aggregates, then monomers and reversible oligomers will be depleted, and the resulting larger aggregates will dominate the scattering signals. As a result, the pre-existing "seeds" cause the reversible "prenuclei" to be effectively undetectable in these experiments. Greatly reducing the seed concentration allows one to directly probe the (average) population of reversible aggregates using scattering, but this is not detectable using SEC because of the need to cool the samples, and the fact that the mobile phase conditions are different from the sample buffer. However, the results for aCgn also show that reversible oligomerization is less detectable at higher total protein concentration and fixed percentage of initial dimer. Based on simple mass-action arguments, higher protein concentration would promote higher concentrations of reversible dimers, trimers and so forth at higher temperatures. However, from a kinetic standpoint the higher protein concentration could also accelerate the conversion of nuclei to irreversible aggregates, as well as the rates of aggregate-aggregate coalescence. Therefore, the relative lack of reversibility in the temperaturecycling experiments, and the simple linear M w vs. t profiles at higher aCgn concentrations may simply be due to the fact that we were unable to probe the SLS behavior on sufficiently short time scales in those cases.
Finally, from a pragmatic perspective, temperature-step kinetic measurements with SLS can provide an effective means to interrogate the reversible vs. irreversible processes, particularly when combined with an orthogonal technique such as SEC. Doing so will allow one to avoid erroneous assumptions about the equivalence of aggregation rates quantified by different techniques, 22 will provide more insight into key mechanistic steps in the overall aggregation process that could be used develop strategies to suppress or promote aggregation, depending the desired application. Overall, a combined approach of ex situ SEC and in situ SLS with temperature cycling can provide a generally useful means to interrogate and potentially quantify key intermediates in the non-native aggregation process for proteins more generally, beyond the aCgn example shown here.
Materials and Methods
In the interest of space constraints, details of sample preparation, size-exclusion chromatography, isothermal temperature-cycling laser scattering, and PTIR analysis are provided in Supporting Information.
